Vaxart Inc (VXRT)
0.7289
-0.02
(-2.68%)
USD |
NASDAQ |
May 03, 16:00
0.7419
+0.01
(+1.78%)
After-Hours: 20:00
Vaxart Price to Book Value: 2.166 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 2.253 |
| May 01, 2024 | 2.107 |
| April 30, 2024 | 2.150 |
| April 29, 2024 | 2.145 |
| April 26, 2024 | 2.135 |
| April 25, 2024 | 1.980 |
| April 24, 2024 | 2.135 |
| April 23, 2024 | 2.242 |
| April 22, 2024 | 2.293 |
| April 19, 2024 | 2.273 |
| April 18, 2024 | 2.533 |
| April 17, 2024 | 2.605 |
| April 16, 2024 | 2.690 |
| April 15, 2024 | 2.734 |
| April 12, 2024 | 2.737 |
| April 11, 2024 | 3.128 |
| April 10, 2024 | 3.038 |
| April 09, 2024 | 3.128 |
| April 08, 2024 | 3.248 |
| April 05, 2024 | 3.248 |
| April 04, 2024 | 3.399 |
| April 03, 2024 | 3.700 |
| April 02, 2024 | 3.730 |
| April 01, 2024 | 3.91 |
| March 28, 2024 | 3.91 |
| Date | Value |
|---|---|
| March 27, 2024 | 3.88 |
| March 26, 2024 | 3.669 |
| March 25, 2024 | 3.700 |
| March 22, 2024 | 3.790 |
| March 21, 2024 | 3.700 |
| March 20, 2024 | 3.730 |
| March 19, 2024 | 3.489 |
| March 18, 2024 | 3.489 |
| March 15, 2024 | 3.248 |
| March 14, 2024 | 3.308 |
| March 13, 2024 | 3.399 |
| March 12, 2024 | 3.429 |
| March 11, 2024 | 3.459 |
| March 08, 2024 | 3.579 |
| March 07, 2024 | 3.339 |
| March 06, 2024 | 3.504 |
| March 05, 2024 | 3.533 |
| March 04, 2024 | 3.577 |
| March 01, 2024 | 3.650 |
| February 29, 2024 | 3.562 |
| February 28, 2024 | 3.782 |
| February 27, 2024 | 3.708 |
| February 26, 2024 | 3.592 |
| February 23, 2024 | 3.708 |
| February 22, 2024 | 4.088 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2939
Minimum
Sep 26 2019
46.01
Maximum
Jul 14 2020
4.234
Average
3.134
Median
Feb 03 2022
Price to Book Value Benchmarks
| Novavax Inc | -- |
| aTyr Pharma Inc | 1.196 |
| Allogene Therapeutics Inc | 1.012 |
| AIM ImmunoTech Inc | 2.127 |
| Protalix BioTherapeutics Inc | 2.492 |
Price to Book Value Related Metrics
| PS Ratio | 11.24 |
| Price | 0.7289 |
| Earnings Yield | -80.56% |
| Market Cap | 125.18M |